WASHINGTON (Reuters) - U.S. drug reviewers asked advisers to consider if Arena Pharmaceuticals' obesity pill lorcaserin raised the risk of tumors and heart problems.https://mf.feeds.reuters.com/c/871/f/...f1fa355/mf.gifhttps://res3.feedsportal.com/images/emailthis2.gifhttps://res3.feedsportal.com/images/bookmark.gif
https://da.feedsportal.com/r/13351534...f1fa355/a2.imghttps://pi.feedsportal.com/r/13351534...1fa355/a2t.img
More...
